X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (491) 491
Journal Article (349) 349
Conference Proceeding (46) 46
Publication (11) 11
Book Review (6) 6
Book Chapter (3) 3
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (214) 214
metallurgy (213) 213
physics (182) 182
performing operations (173) 173
transporting (173) 173
human necessities (154) 154
compositions based thereon (139) 139
organic macromolecular compounds (139) 139
their preparation or chemical working-up (139) 139
index medicus (116) 116
electricity (112) 112
amusements (83) 83
games (83) 83
sports (83) 83
after-treatment of the shaped products, e.g. repairing (79) 79
shaping of material in a plastic state, not otherwise providedfor (79) 79
shaping or joining of plastics (79) 79
working of plastics (79) 79
working of substances in a plastic state, in general (79) 79
basic electric elements (71) 71
humans (71) 71
hygiene (67) 67
medical or veterinary science (67) 67
compositions of macromolecular compounds (63) 63
layered products (63) 63
layered products, i.e. products built-up of strata of flat ornon-flat, e.g. cellular or honeycomb, form (63) 63
optics (62) 62
card, board, or roulette games (60) 60
games not otherwise provided for (60) 60
indoor games using small moving playing bodies (60) 60
video games (60) 60
use of inorganic or non-macromolecular organic substances ascompounding ingredients (59) 59
optical elements, systems, or apparatus (54) 54
electric solid state devices not otherwise provided for (53) 53
semiconductor devices (53) 53
measuring (52) 52
testing (52) 52
biochemistry (49) 49
macromolecular compounds obtained by reactions only involvingcarbon-to-carbon unsaturated bonds (49) 49
microbiology (49) 49
general tagging of cross-sectional technologies spanning over several sections of the ipc (48) 48
general tagging of new technological developments (48) 48
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (48) 48
beer (47) 47
enzymology (47) 47
mutation or genetic engineering (47) 47
spirits (47) 47
vinegar (47) 47
wine (47) 47
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (44) 44
investigating or analysing materials by determining theirchemical or physical properties (43) 43
cinematography (42) 42
electrography (42) 42
holography (42) 42
photography (42) 42
female (41) 41
indexing scheme associated with subclass b29c, relating to particulararticles (40) 40
male (40) 40
preparations for medical, dental, or toilet purposes (39) 39
surgery (39) 39
adhesives (38) 38
animals (38) 38
dyes (38) 38
miscellaneous applications of materials (38) 38
miscellaneous compositions (38) 38
natural resins (38) 38
paints (38) 38
polishes (38) 38
after-treatment not covered by subclasses c08b, c08c, c08f,c08g (36) 36
general processes of compounding (36) 36
working-up (36) 36
electric communication technique (33) 33
technical subjects covered by former uspc (33) 33
conveying (31) 31
diagnosis (31) 31
handling thin or filamentary material (31) 31
identification (31) 31
packing (31) 31
storing (31) 31
chemical paint or ink removers (29) 29
coating compositions, e.g. paints, varnishes orlacquers (29) 29
correcting fluids (29) 29
filling pastes (29) 29
indexing scheme associated with subclasses b29b, b29c or b29d, relating to moulding materials (29) 29
inks (29) 29
pastes or solids for colouring or printing (29) 29
technical subjects covered by former us classification (29) 29
use of materials therefor (29) 29
woodstains (29) 29
electrophotography (28) 28
magnetography (28) 28
mice (28) 28
compositions or test papers therefor (27) 27
condition-responsive control in microbiological orenzymological processes (27) 27
measuring or testing processes involving enzymes, nucleicacids or microorganisms (27) 27
processes of preparing such compositions (27) 27
aged (26) 26
middle aged (26) 26
technologies or applications for mitigation or adaptation againstclimate change (26) 26
calculating (25) 25
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (846) 846
Japanese (128) 128
French (96) 96
Chinese (54) 54
German (54) 54
Korean (12) 12
Spanish (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 9239 - 11
The interplay between food components and gut microbiota has been considered an important factor affecting the functionality of health-promoting foods. In this... 
BIOACTIVITY | FLAVONOID GLYCOSIDES | COMPOUND K | MULTIDISCIPLINARY SCIENCES | ENHANCEMENT | HUMANS | GINSENG | DEGRADATION | GUT MICROBIOTA | GINSENOSIDES | MASS-SPECTROMETRY | Vegetables | Kaempferol | Oral administration | Superoxide dismutase | Bioconversion | Bioavailability | Probiotics | Microbiota | Fatty liver | Intestine | Aging | Pharmacokinetics | Glucosides
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, pp. e109288 - e109288
Cu-Zn superoxide dismutase (Sod1) loss causes a redox imbalance as it leads to excess superoxide generation, which results in the appearance of various... 
LIFE-SPAN | OXIDATIVE STRESS | CAENORHABDITIS-ELEGANS | COLLAGEN | SOD1-DEFICIENT MICE | MULTIDISCIPLINARY SCIENCES | DEGRADATION | ACCUMULATION | FIBROBLASTS | AGE | DEGENERATION | Skin Aging - pathology | Superoxide Dismutase - genetics | Reactive Oxygen Species - metabolism | Skin - metabolism | Atrophy - pathology | Platinum - administration & dosage | Nanoparticles - therapeutic use | Atrophy - drug therapy | Wound Healing - drug effects | Skin - pathology | Superoxide Dismutase - metabolism | Platinum - therapeutic use | Skin Aging - drug effects | Hydrogen Peroxide - metabolism | Mice, Knockout | Palladium - administration & dosage | Antioxidants - therapeutic use | Animals | Palladium - therapeutic use | Antioxidants - administration & dosage | Mice | Nanoparticles - administration & dosage | Oxidative Stress - drug effects | Atrophy - metabolism | Skin - drug effects | Antioxidants | Nanoparticles | Zinc compounds | Care and treatment | Skin | Palladium | Superoxide | Tumor proteins | Gene expression | Collagen (type I) | p53 Protein | Lipid peroxidation | Superoxide dismutase | Catalytic activity | Kinases | Interleukin 6 | Atrophy | Vitiligo | Catalase | Platinum | Older people | Rodents | Fibroblasts | Aging | Skin diseases | Oxidation | Catalysis | Copper | Deoxyribonucleic acid--DNA | Age | University graduates | Peroxidation | Medical treatment | Inflammation | Tumor necrosis factor-α | Aging (metallurgy) | Zinc | Gelatinase A | Medicine | Gerontology | Collagen | Noble metals | Alzheimers disease | Pharmaceuticals | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Plant Molecular Biology, ISSN 0167-4412, 3/2014, Volume 84, Issue 4, pp. 519 - 528
Journal Article
Carbon, ISSN 0008-6223, 12/2019, Volume 154, pp. 7 - 12
Diamond-like carbon (DLC) is one of the most promising solid lubricants for sliding against other materials, such as steel, alumina, and silicon carbide (SiC).... 
Journal Article
Cancer Science, ISSN 1347-9032, 04/2017, Volume 108, Issue 4, pp. 763 - 771
The combination of lenvatinib, a multiple receptor tyrosine kinase inhibitor, plus everolimus, a mammalian target of rapamycin ( mTOR ) inhibitor,... 
everolimus | renal cell carcinoma | fibroblast growth factor | lenvatinib | Combination | ACTIVATION | SUPPRESSOR GENE | CANCER | RENAL-CELL CARCINOMA | HYPOXIA-INDUCIBLE FACTORS | E7080 | THERAPY | ONCOLOGY | PATHWAY | TYROSINE KINASE INHIBITOR | EXPRESSION | Kidney Neoplasms - genetics | TOR Serine-Threonine Kinases - metabolism | Humans | Carcinoma, Renal Cell - genetics | Everolimus - administration & dosage | Fibroblast Growth Factor 1 - genetics | Kidney Neoplasms - metabolism | Vascular Endothelial Growth Factor A - metabolism | Quinolines - administration & dosage | Vascular Endothelial Growth Factor A - genetics | Quinolines - pharmacology | TOR Serine-Threonine Kinases - genetics | Fibroblast Growth Factor 2 - metabolism | Neovascularization, Pathologic - prevention & control | Tumor Burden - genetics | Carcinoma, Renal Cell - drug therapy | Cell Proliferation - genetics | Everolimus - pharmacology | Cells, Cultured | Fibroblast Growth Factor 1 - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Xenograft Model Antitumor Assays - methods | Blotting, Western | Drug Synergism | Carcinoma, Renal Cell - metabolism | Animals | Fibroblast Growth Factor 2 - genetics | Phenylurea Compounds - administration & dosage | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Neovascularization, Pathologic - metabolism | Phenylurea Compounds - pharmacology | Kidney Neoplasms - drug therapy | Tyrosine | Endothelial growth factors | Growth | Analysis | Fibroblast growth factors | Metastasis | Gene expression | Endothelium | Index Medicus | Original
Journal Article